Alfresa Holdings Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 15,610

Employees

  • Stock Symbol
  • 2784

Stock Symbol

  • Investments
  • 42

  • Share Price
  • $14.56
  • (As of Friday Closing)

Alfresa Holdings General Information

Description

Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.

Contact Information

Website
www.alfresa.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1-1-3 Otemachi
  • Chiyoda-ku
  • Tokyo, 100-0004
  • Japan
+81
Primary Industry
Holding Companies
Stock Exchange
TKS
Corporate Office
  • 1-1-3 Otemachi
  • Chiyoda-ku
  • Tokyo, 100-0004
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alfresa Holdings Stock Performance

As of 20-Nov-2026, Alfresa Holdings’s stock price is $14.56. Its current market cap is $2.55B with 175M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.56 $14.78 $13.19 - $17.23 $2.55B 175M 440K $1.35

Alfresa Holdings Financials Summary

As of 30-Sep-2026, Alfresa Holdings has a trailing 12-month revenue of $20.1B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 1,511,017 1,671,205 1,431,293 1,604,439
Revenue 20,059,637 20,594,232 19,416,968 19,783,398
EBITDA 473,410 511,083 356,837 397,135
Net Income 244,403 276,968 179,602 204,568
Total Assets 9,760,132 9,427,217 9,622,176 9,564,751
Total Debt 190,578 222,823 237,533 230,836
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alfresa Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alfresa Holdings‘s full profile, request access.

Request a free trial

Alfresa Holdings Patents

Alfresa Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-240848-U Extractor applicable in the disassembly of hormi-gon and similar formwork. Active 19-Jan-1979
ES-240847-U Perfected arrangement for the assembly of concrete and similar formwork. Active 19-Jan-1979
ES-240847-Y Perfected arrangement for the assembly of concrete forms and the like. Inactive 19-Jan-1979
ES-237026-U Device for the assembly of concrete and similar formwork. Active 30-Jun-1978
ES-226543-U Tone frequency modulator. Active 19-Feb-1977
To view Alfresa Holdings’s complete patent history, request access »

Alfresa Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alfresa Holdings Investments & Acquisitions (42)

Alfresa Holdings’s most recent deal was a PIPE with Mycenax for . The deal was made on 09-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mycenax 09-Nov-2026 PIPE Biotechnology
Sega Sammy Holdings (Sega Sammy Baseball Club) 14-Jul-2026 Merger/Acquisition Education and Training Services (B2B)
Nagashima Medical Instruments 27-May-2026 Merger/Acquisition Surgical Devices
ReeNT 27-May-2026 Later Stage VC Drug Discovery
Intellim (Staffing Business, Cro Outsourcing and Contracting Business) 31-Mar-2026 Merger/Acquisition BPO/Outsource Services
You’re viewing 5 of 42 investments and acquisitions. Get the full list »

Alfresa Holdings ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

16.82 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view Alfresa Holdings’s complete esg history, request access »

Alfresa Holdings Exits (3)

Alfresa Holdings’s most recent exit was on 21-Aug-2025 from Innovacell. The exit was categorized as with 9 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Innovacell 21-Aug-2025 Completed
  • 9 buyers
NC Medical Research 05-Aug-2021 Completed
  • 3 buyers
Taishodo 01-Jul-2004 Merger/Acquisition Completed
To view Alfresa Holdings’s complete exits history, request access »

Alfresa Holdings Affiliates

Subsidiaries (14)

Name Industry Location Year Founded
ArkMS Tokyo, Japan 2024
Tohoku Alfressa Sendai City, Japan 2018
Alfresa System Kk Tokyo, Japan 2007
Astrana Health Alhambra, CA 1992
Techno Suzuta Nagasaki, Japan 1953
You’re viewing 5 of 14 affiliates. Get the full list.  »

Alfresa Holdings FAQs

  • When was Alfresa Holdings founded?

    Alfresa Holdings was founded in 2003.

  • Where is Alfresa Holdings headquartered?

    Alfresa Holdings is headquartered in Tokyo, Japan.

  • What is the size of Alfresa Holdings?

    Alfresa Holdings has 15,610 total employees.

  • What industry is Alfresa Holdings in?

    Alfresa Holdings’s primary industry is Holding Companies.

  • Is Alfresa Holdings a private or public company?

    Alfresa Holdings is a Public company.

  • What is Alfresa Holdings’s stock symbol?

    The ticker symbol for Alfresa Holdings is 2784.

  • What is the current stock price of Alfresa Holdings?

    As of 20-Nov-2026 the stock price of Alfresa Holdings is $14.56.

  • What is the current market cap of Alfresa Holdings?

    The current market capitalization of Alfresa Holdings is $2.55B.

  • What is Alfresa Holdings’s current revenue?

    The trailing twelve month revenue for Alfresa Holdings is $20.1B.

  • What is Alfresa Holdings’s annual earnings per share (EPS)?

    Alfresa Holdings’s EPS for 12 months was $1.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process